Related Experiment Video
Updated: Feb 2, 2026

08:17
Reducing State Anxiety Using Working Memory Maintenance
Published on: July 19, 2017
8.2K
Imepitoin Shows Benzodiazepine-Like Effects in Models of Anxiety
Odilo Engel1, Aleksandar Masic2, Gary Landsberg2
1Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany.
Frontiers in Pharmacology
|November 21, 2018
Summary
Imepitoin demonstrates anxiolytic properties in preclinical models and dogs, similar to benzodiazepines but without causing sedation. This suggests potential as a novel anti-anxiety medication.
Area of Science:
- Neuroscience
- Pharmacology
- Veterinary Medicine
Background:
- Imepitoin is an antiepileptic drug acting as a partial agonist at GABAA receptors.
- Existing antiepileptics may have anxiolytic potential.
- Benzodiazepines are effective anxiolytics but cause sedation.
Purpose of the Study:
- To investigate the anxiolytic properties of imepitoin.
- To compare imepitoin's anxiolytic profile with benzodiazepines.
- To assess imepitoin's efficacy and safety in animal models of anxiety.
Main Methods:
- In vitro testing on locus coeruleus neurons.
- Rodent behavioral tests: elevated plus maze, light-dark box, social interaction, Vogel conflict test.
- Canine sound-induced fear model with cortisol level assessment.
Main Results:
- Imepitoin reduced corticotrophin-releasing factor effects on neurons in vitro.
- Imepitoin exhibited anxiolytic-like behavior across rodent models.
- In dogs, imepitoin increased locomotion and reduced cortisol levels during sound-induced fear, unlike dexmedetomidine.
- Anxiolytic doses were not associated with sedation in any model.
Conclusions:
- Imepitoin possesses significant anxiolytic activity.
- Its mechanism and lack of sedation differentiate it from traditional benzodiazepines.
- Imepitoin shows promise as a non-sedating anxiolytic agent.
Related Concept Videos
Sedatives and Hypnotics Drugs: Benzodiazepines
905
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
905
Anxiety: Overview
1.0K
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
1.0K
CNS Depressants: Barbiturates and Benzodiazepines
1.4K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.4K
Anxiolytic Drugs: Benzodiazepines and Buspirone
2.5K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.5K
Generalized Anxiety Disorder
704
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
704
Social Anxiety Disorder
525
Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.
525

